Biologic Videos

31. Formulating The Future: A Practical Guide To Nucleic Acid Therapeutics 4/14/2026

    An expert-led webinar exploring nucleic acid therapeutic modalities, delivery systems, formulation challenges, and real-world case studies shaping drug product development.

32. Inside Asymchem's Technology-Led Expansion Of Oligonucleotide Capabilities 4/13/2026

    Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.

33. Flow Solutions For Pharmaceutical Manufacturing 4/13/2026

    Rising molecular complexity and tighter timelines push manufacturing beyond batch processes. Continuous, automated flow enables faster scale-up, safer handling, and efficiency without sacrificing quality.

34. Asymchem's Enzyme-Powered Innovations In Manufacturing 4/13/2026

    Advances in enzyme engineering, AI, and automation are enabling more precise, scalable biomanufacturing. See how continuous processes and synthetic biology are expanding what’s possible for complex therapies.

35. ADC Payloader-Linker CMC Process Development Strategy 4/13/2026

    Shows how payload‑linker CMC planning differs from clinical to commercial, what drives route and RSM decisions, and how QC shifts from release testing to CQA‑linked specs, illustrated with IND vs NDA.

36. Mississauga Site Wins With Bora Pharmaceuticals 4/13/2026

    Years of collaboration turned complexity into a seamless, predictable workflow. Shared language, aligned documentation, and trust now speed progress and support faster, more confident execution.

37. Customer Success At Bora Pharmaceuticals 4/13/2026

    Equipment installs are rarely simple. See how upfront planning, smart inventory strategy, and disciplined execution enabled a complex line upgrade without disrupting products or commitments.

38. From Bench To Approval: Smart IVBE Strategies For Complex Drugs 4/10/2026

    In vitro bioequivalence can replace clinical studies for complex products when well designed. Clinically relevant, risk-based methods under realistic conditions show site-of-action equivalence.

39. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

40. From Clinical To Commercial: Introducing Devices Earlier To Streamline The DDC Journey 4/8/2026

    Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.